Results of antiestrogen therapy in metastasizing breast cancer
Firusian, N.; Schmidt, C.G.
Die Medizinische Welt 28(50): 2035-2039 Contd
1977
ISSN/ISBN: 0025-8512 PMID: 414048 Document Number: 113605
Document emailed within 1 workday
Related Documents
Lippman, M.E. 1983: Antiestrogen therapy of breast cancer Seminars in Oncology 10(4 Suppl 4: 11-19Köhler, A.; Noss, W.; Dobberstein, N.; Stoltmann, R.; Pohl, J. 1986: Hormone therapy of metastasizing breast cancer with tamoxifen Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(1): 6-9
Nomura, Y.; Yamagata, J.; Kondo, H.; Takenaka, K. 1978: Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay Gan 69(2): 281-282
Alba, E.; Ragonesi, G.; Colla, F.; Mazzoleni, A.; Farina, C. 2002: Antiestrogen therapy in the treatment of breast neoplasms Minerva Ginecologica 54(3): 245-251
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Pearson, O.H.; Manni, A.; Arafah, B.M. 1982: Antiestrogen treatment of breast cancer: an overview Cancer Research 42(8 Suppl): 3424s-3429s
Manni, A.; Trujillo, J.; Marshall, J.S.; Pearson, O.H. 1976: Antiestrogen-induced remissions in stage IV breast cancer Cancer Treatment Reports 60(10): 1445-1450
Telhaug, R.; Fosså, S.D.; Lund, G.; Børmer, O. 1982: Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(34-36): 1849-1851
1991: Therapeutic advantages of droloxifene, a new antiestrogen, in breast cancer. Proceedings of a satellite symposium held during the 15th International Cancer Congress. Hamburg, F.R.G., August 18, 1990 American Journal of Clinical Oncology 14 Suppl. 2: S1-63
Viladiu, P.; Bosch, F.X.; Benito, E.; Alonso, M.C. 1977: Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients Cancer Treatment Reports 61(5): 899-900
Braun, E.; Queisser, W. 1975: Management of metastasizing breast cancer Fortschritte der Medizin 93(35-36): 1764-1772
Rasmussen, K.S.; Kristensen, P.B.; Adolfsen, N.J. 1983: Breast cancer metastasizing to the uterus Ugeskrift for Laeger 145(45): 3493-3494
Hartenstein, R.; Ehrhart, H.; Pape, W. 1977: Medical therapy of the metastasizing breast neoplasm Fortschritte der Medizin 95(19): 1305-1312
Bardon, S.; Vignon, F.; Montcourrier, P.; Rochefort, H. 1987: Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells Cancer Research 47(5): 1441-1448
Wöllgens, P.; Untucht, H.J. 1973: Palliative radiotherapy in metastasizing breast cancer Zeitschrift für Allgemeinmedizin 49(34): 1693-1694
Biersack, H.J.; Kozak, B.; Winkler, C.; Hartlapp, A. 1985: Bone scan in metastasizing breast cancer Deutsche Medizinische Wochenschrift 110(3): 116-117
Muller-Plettenberg, D. 1982: Current aspects of therapy in metastasizing breast carcinoma Therapie der Gegenwart 121(1): 44-45
Lenzhofer, R.; Rainer, H.; Schuster, R.; Pirker, P.; Dudczak, R.; Dittrich, C.; Moser, K. 1984: Mitoxantrone in the primary treatment of metastasizing breast cancer Wiener Klinische Wochenschrift 96(9): 319-326
Benedetto, G. di; Gallamini, A.; Nizzo, M.C.; Costa, M.; Indiveri, F. 1976: Effects of the treatment with an antiestrogen(tamoxifen) and levodopa on the secretion of prolactin in patients affected by breast cancer Bollettino della Societa Italiana di Biologia Sperimentale 52(19): 1572-1575
Diel, I.J.; Solomayer, E.F. 1996: Bisphosphonates in anti-osteolytic therapy of metastasizing breast carcinoma Zentralblatt für Gynakologie 118(10): 582-586